Comprehensive information on 10,000+ stocks and funds, including all the companies in the S&P 500 index. See stock prices, news, social sentiment, financials, forecasts, business, management and more.
As of the morning of August 6, 2026, U.S. stocks are edging slightly lower after a very strong start to August. Rising oil prices and another heavy wave of earnings are the main macro drivers, with investors cautious after recent record or near‑record highs for the major indices. (apnews.com)
The broader backdrop is that the S&P 500 and Dow have recently been trading in record-high territory on the back of strong earnings, particularly in technology and AI‑related names. At the same time, there is growing concern that valuations in parts of tech and AI have become stretched after a powerful multi‑month rally. (apnews.com)
Geopolitics and commodities remain in focus. Hopes for progress on an Iran-related agreement had recently supported risk assets, but fresh gains in crude oil are pressuring sentiment and feeding the narrative that August could be more volatile than the first half of the year. (apnews.com)
| Date | Ticker | Company Name | Offer Amount |
|---|---|---|---|
| Aug 5 | ATTO | Attovia Therapeutics, Inc. | $289,000,000 |
| Aug 5 | TCGX | TCGX Acquisition Corp. | $75,000,000 |
| Aug 4 | THEOU | BOA Acquisition Corp. II | $125,000,000 |
| Aug 4 | FJDIU | ARC Group Securities Acquisition I | $105,000,000 |
| Jul 31 | APMD | Apnimed, Inc. | $192,000,000 |
| Date | Ticker | Company Name | Offer Amount |
|---|---|---|---|
| Aug 6 | BRVE | Braveheart Bio, Inc. | $382,500,000 |
| Aug 6 | OCLTU | OceanLight Acquisition Corp | $115,000,000.00 |
| Aug 7 | LTGO | Latigo Biotherapeutics, Inc. | $331,200,000 |
| Aug 7 | BLSM | BlossomHill Therapeutics, Inc. | $152,734,375 |